Tanimoto Sarina 13D/13G Filings for ARS Pharmaceuticals, Inc. (SPRY)

Tanimoto Sarina 13D and 13G filings for ARS Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-11-18
1:58 pm
Purchase
2022-11-08 13D ARS Pharmaceuticals, Inc.
SPRY
Tanimoto Sarina 6,265,170
6.700%
6,265,170increase
(New Position)
Filing